SCHEMBL4714563

SCHEMBL4714563

CC(CCC(N)=O)c1ccc2nc(Oc3ccc(Nc4ccc5ccccc5c4)cc3)sc2c1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 1/20 0.41
P2RX3 P56373 1/20 0.40
CYP26A1 O43174 5/20 0.38
CYP1A2 P05177 2/20 0.38
CYP3A4 P08684 2/20 0.38
CYP2D6 P10635 2/20 0.38
CYP2C19 P33261 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
DHODH Q02127 2/20 0.38
SCD O00767 1/20 0.37
PIN1 Q13526 2/20 0.37
CTSD P07339 1/20 0.37
PPARG P37231 1/20 0.36
PPARD Q03181 1/20 0.36
PPARA Q07869 1/20 0.36
TNIK Q9UKE5 3/20 0.36
CYP2C9 P11712 1/20 0.36
LTA4H P09960 1/20 0.36
KCNH2 Q12809 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4508992 0.85 NPC1 (0.41) PTGDR2P2RX3CYP26A1CYP1A2CYP3A4
SCHEMBL4511372 0.78 NPC1 (0.44) P2RX3CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL4520509 0.75 NPC1 (0.44) CYP1A2CYP3A4CYP2D6CYP2C19SMN1; SMN2
SCHEMBL4518430 0.73 NPC1 (0.43) P2RX3CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL15252374 0.73 SMN1; SMN2 (0.49) CYP1A2CYP3A4CYP2D6CYP2C19SMN1; SMN2
SCHEMBL4519186 0.72 NPC1 (0.52) CYP1A2CYP3A4CYP2D6CYP2C19SMN1; SMN2
SCHEMBL2622429 0.71 SMN1; SMN2 (0.49) CYP1A2CYP3A4CYP2D6CYP2C19SMN1; SMN2
SCHEMBL2622428 0.71 ACACB (0.48) CYP1A2CYP3A4CYP2D6CYP2C19SMN1; SMN2
SCHEMBL18269847 0.70 SMN1; SMN2 (0.48) CYP1A2CYP3A4CYP2D6CYP2C19SMN1; SMN2
SCHEMBL4790440 0.70 ACACB (0.41) CYP1A2CYP3A4CYP2D6CYP2C19SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1996567-A2 NOVEL ACETYL-COA CARBOXYLASE (ACC) INHIBITORS AND THEIR USE IN DIABETES, OBESITY AND METABOLIC SYNDROME ABBOTT LABORATORIES (US) 2008-12-03 EP claimed
WO-2007095601-A2 NOVEL ACETYL-COA CARBOXYLASE (ACC) INHIBITORS AND THEIR USE IN DIABETES, OBESITY AND METABOLIC SYNDROME ABBOTT LABORATORIES (US) 2007-08-23 WO claimed